Key result
MitraClip therapy is a safe percutaneous procedure for severe mitral regurgitation, with survival outcomes in high-surgical-risk patients superior to historical controls.
Why the study?
Does percutaneous edge-to-edge repair (MitraClip) improve outcomes in patients with severe mitral regurgitation at high surgical risk?
Does percutaneous edge-to-edge repair (MitraClip) improve outcomes in patients with severe mitral regurgitation at high surgical risk?
Answers are grounded in this paper and cite their sources.
MitraClip is a safe percutaneous option for severe mitral regurgitation, particularly in high-surgical-risk patients, though long-term durability remains to be fully established.
MitraClip® therapy is a percutaneous edge-to-edge plication of the mitral leaflets, mimicking the Alfieri surgical technique. MitraClip® implantation is a safe procedure, and survival outcomes in high-surgical-risk patients are superior to historical controls. Despite these results, questions remain concerning long-term efficacy and durability. The MitraClip® device has been studied in a safety and feasibility trial in the USA, a randomized pivotal trial against surgical mitral valve repair. Moreover, MitraClip® now has over 2 years of CE-mark approval and a rapidly expanding clinical experience in Europe, primarily in patients at high risk for surgery. A dedicated multidisciplinary team is necessary, as well as thoughtful patient selection, familiarity with the technical aspects of the procedure, including transesophageal ultrasound imaging and post-procedure monitoring. Currently available clinical data and procedural steps are herein reviewed. Because the MitraClip® procedure is still relatively new, continued investigation is required to further better define the patient populations that will benefit most.
No takes yet. Share an insight, caveat, or question.
Alegría‐Barrero et al. (2012) conducted a review in Severe Mitral Regurgitation. MitraClip was evaluated. MitraClip therapy is a safe percutaneous procedure for severe mitral regurgitation, with survival outcomes in high-surgical-risk patients superior to historical controls.
Synapse has enriched 10 related papers. Consider them for comparative context: